These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

546 related items for PubMed ID: 19121451

  • 1. Comparison of Nebivolol monotherapy versus Nebivolol in combination with other antihypertensive therapies for the treatment of hypertension.
    Papademetriou V.
    Am J Cardiol; 2009 Jan 15; 103(2):273-8. PubMed ID: 19121451
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
    Germino FW.
    Clin Ther; 2009 Sep 15; 31(9):1946-56. PubMed ID: 19843484
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and tolerability of nebivolol in stage I-II hypertension: a pooled analysis of data from three randomized, placebo-controlled monotherapy trials.
    Weiss RJ, Saunders E, Greathouse M.
    Clin Ther; 2011 Sep 15; 33(9):1150-61. PubMed ID: 21864908
    [Abstract] [Full Text] [Related]

  • 4. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW.
    Clin Ther; 2009 Mar 15; 31(3):447-62. PubMed ID: 19393838
    [Abstract] [Full Text] [Related]

  • 5. Placebo effect and efficacy of nebivolol in patients with hypertension not controlled with lisinopril or losartan: a phase IV, randomized, placebo-controlled trial.
    Weiss RJ, Stapff M, Lin Y.
    Am J Cardiovasc Drugs; 2013 Apr 15; 13(2):129-40. PubMed ID: 23519546
    [Abstract] [Full Text] [Related]

  • 6. Nationwide efficacy-safety study of nebivolol in mildly hypertensive patients.
    Cleophas TJ, Agrawal R, Lichtenthal A, Mäkel W, Fici F.
    Am J Ther; 2006 Apr 15; 13(3):192-7. PubMed ID: 16772759
    [Abstract] [Full Text] [Related]

  • 7. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD, Mion D, Rocha JC, Kohlmann O, Gomes MA, Saraiva JF, Amodeo C, Filho BL.
    Clin Ther; 2008 Sep 15; 30(9):1618-28. PubMed ID: 18840367
    [Abstract] [Full Text] [Related]

  • 8. Nebivolol monotherapy for patients with systolic stage II hypertension: results of a randomized, placebo-controlled trial.
    Lewin A, Punzi H, Luo X, Stapff M.
    Clin Ther; 2013 Feb 15; 35(2):142-52. PubMed ID: 23332366
    [Abstract] [Full Text] [Related]

  • 9. [Nebivolol, a third generation beta blocker: the modern treatment of hypertension. Results of a multicentric observational study].
    von Fallois J, Faülhaber HD.
    Fortschr Med Orig; 2000 Jul 27; 118 Suppl 2():77-82. PubMed ID: 15700490
    [Abstract] [Full Text] [Related]

  • 10. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH, Kim YD, Lim DS, Yoon MH, Ahn YK, On YK, Lee JW, Kim IJ, Park JB, Kim JJ, Chung WS, Yang JY, Seo HS, Shin EK, Kim HS, Korean Multicenter Amlodipine Study Investigators.
    Clin Ther; 2007 Sep 27; 29(9):1924-36. PubMed ID: 18035192
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and tolerability profile of nebivolol vs atenolol in mild-to-moderate essential hypertension: results of a double-blind randomized multicentre trial.
    Grassi G, Trevano FQ, Facchini A, Toutouzas T, Chanu B, Mancia G.
    Blood Press Suppl; 2003 Dec 27; 2():35-40. PubMed ID: 14761075
    [Abstract] [Full Text] [Related]

  • 12. A multicenter, randomized, double-blind, parallel-group trial of the antihypertensive efficacy and tolerability of a combination of once-daily losartan 100 mg/hydrochlorothiazide 12.5 mg compared with losartan 100-mg monotherapy in the treatment of mild to severe essential hypertension.
    Gleim GW, Rubino J, Zhang H, Shahinfar S, Soffer BA, Lyle PA, Littlejohn TW, Feig PU.
    Clin Ther; 2006 Oct 27; 28(10):1639-48. PubMed ID: 17157119
    [Abstract] [Full Text] [Related]

  • 13. The role of the new beta-blockers in treating cardiovascular disease.
    Weber MA.
    Am J Hypertens; 2005 Dec 27; 18(12 Pt 2):169S-176S. PubMed ID: 16373195
    [Abstract] [Full Text] [Related]

  • 14. [Nebivolol, a beta blocker of the 3rd generation: modern therapy of arterial hypertension. Results of a multicenter observation study].
    von Fallois J, Faulhaber HD.
    Praxis (Bern 1994); 2001 Mar 15; 90(11):435-41. PubMed ID: 11293936
    [Abstract] [Full Text] [Related]

  • 15. Nebivolol in hypertension: a double-blind placebo-controlled multicenter study assessing its antihypertensive efficacy and impact on quality of life.
    Van Bortel LM, Breed JG, Joosten J, Kragten JA, Lustermans FA, Mooij JM.
    J Cardiovasc Pharmacol; 1993 Jun 15; 21(6):856-62. PubMed ID: 7687708
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study.
    Giles TD, Weber MA, Basile J, Gradman AH, Bharucha DB, Chen W, Pattathil M, NAC-MD-01 Study Investigators.
    Lancet; 2014 May 31; 383(9932):1889-98. PubMed ID: 24881993
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and tolerability of nebivolol: does age matter? A retrospective analysis of three randomized, placebo-controlled trials in stage I-II hypertension.
    Germino FW, Lin Y, Pejović V, Bowen L.
    Ther Adv Cardiovasc Dis; 2012 Oct 31; 6(5):185-99. PubMed ID: 23008339
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.
    Calhoun DA, Glazer RD, Pettyjohn FS, Coenen PD, Zhao Y, Grosso A.
    Curr Med Res Opin; 2008 Aug 31; 24(8):2303-11. PubMed ID: 18593517
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of nebivolol in Hispanics with stage I-II hypertension: a randomized placebo-controlled trial.
    Punzi H, Lewin A, Lukić T, Goodin T, Wei Chen.
    Ther Adv Cardiovasc Dis; 2010 Dec 31; 4(6):349-57. PubMed ID: 21088095
    [Abstract] [Full Text] [Related]

  • 20. Nebivolol: in the treatment of hypertension in the US.
    Baldwin CM, Keam SJ.
    Am J Cardiovasc Drugs; 2009 Dec 31; 9(4):253-60. PubMed ID: 19655820
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.